Nventa Biopharma News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Natural Drug Treatments Offer Promise, Potential as Savvy Drug Developers Recognize True Opportunities
- NetworkNewsWire Editorial Coverage
NEW YORK, May 20, 2021 /PRNewswire/ Before government legislation brought the world of psychedelic drug compounds to a halt, promising research was being done in the space. As researchers and scientists took closer looks at substances such as psilocybin, ketamine, DMT (dimethyltryptamine), LSD (lysergic acid diethylamide) and more, the potential for the compounds appeared to be widespread and even life-changing for many who struggled with notoriously difficult diseases such as depression, addiction, PTSD and more. And then the Federal Comprehensive Drug Abuse Prevention and Control Act of 1970, known as the Controlled Substance Act, took effect. For decades, the promise of these substances has remained ignored. However, with recent changes in legal guidelines and swings in public opinion, astute researchers - and companies - are show ....

New York , United States , James Gilligan , Nventa Biopharma , William Schmidt , Joel Castellanos , James Kuo , Tom Dorazio , Davidv Sheehan , Gregory Mckee , Robin Carhart Harris , Kostenloser Wertpapierhandel , Bruce Cozadd , Unmatched Leadership Team , Corporate Communications Contact , Seelos Therapeutics Inc , Jazz Pharmaceuticals , Gw Pharmaceuticals Plc , More Affordable Pipeline Development , Fn Media Group , Gw Pharmaceuticals , Tryp Therapeutics Inc , Numinus Wellness Inc , Bracken Group , University Of Florida Jennifer Miller , Exchange Commission ,